Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. United States Clinical Oncology Next Generation Sequencing Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing Centrifuges)
4.2.2. By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis)
4.2.3. By Application (Screening, Companion Diagnostics, Other Diagnostics)
4.2.4. By End Use (Hospitals, Clinics, Laboratories)
4.2.5. By Region
4.2.6. By Company (2022)
4.3. Market Map
4.3.1. By Technology
4.3.2. By Workflow
4.3.3. By Application
4.3.4. By End Use
4.3.5. By Region
5. North-East Clinical Oncology Next Generation Sequencing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.2. By Workflow
5.2.3. By Application
5.2.4. By End Use
6. Mid-west Clinical Oncology Next Generation Sequencing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Workflow
6.2.3. By Application
6.2.4. By End Use
7. West Clinical Oncology Next Generation Sequencing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Workflow
7.2.3. By Application
7.2.4. By End Use
8. South Clinical Oncology Next Generation Sequencing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Workflow
8.2.3. By Application
8.2.4. By End Use
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
10.1. Recent Developments
10.2. Product Launches
10.3. Mergers & Acquisitions
11. United States Clinical Oncology Next Generation Sequencing Market: SWOT Analysis
12. Porter’s Five Forces Analysis
12.1. Competition in the Industry
12.2. Potential of New Entrants
12.3. Power of Suppliers
12.4. Power of Customers
12.5. Threat of Substitute Product
13. Competitive Landscape
13.1. Illumina, Inc.
13.1.1. Business Overview
13.1.2. Company Snapshot
13.1.3. Products & Services
13.1.4. Current Capacity Analysis
13.1.5. Financials (In case of listed)
13.1.6. Recent Developments
13.1.7. SWOT Analysis
13.2. Thermo Fisher Scientific Inc.
13.3. F. Hoffmann-La Roche Ltd.
13.4. Agilent Technologies
13.5. Myriad Genetics
13.6. Beijing Genomics Institute (BGI)
13.7. Perkin Elmer
13.8. Foundation Medicine
13.9. Pacific Bioscience
13.10. Oxford Nanopore Technologies Ltd.
14. Strategic Recommendations
15. About Us & Disclaimer